A detailed history of Skopos Labs, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 1,515 shares of ELV stock, worth $799,162. This represents 0.34% of its overall portfolio holdings.

Number of Shares
1,515
Previous 1,287 17.72%
Holding current value
$799,162
Previous $607 Million 28.81%
% of portfolio
0.34%
Previous 0.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$464.61 - $519.96 $105,931 - $118,550
228 Added 17.72%
1,515 $782 Million
Q4 2023

Feb 09, 2024

BUY
$433.51 - $488.06 $557,927 - $628,133
1,287 New
1,287 $607 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $127B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.